BioRestorative Therapies(BRTX) - 2025 Q3 - Quarterly Results

Financial Results - BioRestorative Therapies, Inc. announced its financial results for Q3 2025 on November 12, 2025[3]. - The company provided a business update alongside the financial results in the press release[3]. Press Release Information - The press release is available as Exhibit 99.1 and includes details regarding the conference call to discuss the results[3]. - The information in the press release should be considered in the context of the company's filings with the SEC[4]. - The press release is not deemed "filed" under the Exchange Act, and its information will not be incorporated by reference into other filings unless specifically identified[5]. Company Classification - The company is classified as an emerging growth company under the Securities Act[2]. Report Signing - The report was signed by Robert Kristal, Chief Financial Officer, on November 12, 2025[11].